Fighting COVID-19 in the West Africa after experiencing the Ebola epidemic

Pourya Gholizadeh1,2, Moussa Sanogo3, Amadou Oumarou4

  • 1Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Limited international travel and prior experience with epidemics like Ebola helped six African nations control the spread of Coronavirus disease 2019 (COVID-19). This review examines their strategies against the pandemic.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) rapidly disseminated globally, with higher mortality in older individuals and those with pre-existing conditions.
  • African countries showed lower COVID-19 expansion compared to other global regions, prompting an investigation into contributing factors.

Purpose of the Study:

  • To evaluate six African countries (Mali, Mauritania, Niger, Guinea, Togo, Djibouti) to understand the reasons for lower Coronavirus disease 2019 (COVID-19) expansion.
  • To analyze the epidemiological, clinical, diagnostic, and preventive strategies employed by these nations against COVID-19.

Main Methods:

  • A questionnaire-based review was conducted with health officials in the selected African countries.
  • Data collected covered aspects of disease exposure, epidemiology, clinical presentation, case definitions, laboratory confirmation, case management, and prevention.

Main Results:

  • Low international flight volumes and reduced domestic travel significantly limited the initial spread and prevalence of Coronavirus disease 2019 (COVID-19).
  • The return of immigrants contributed to the disease's dissemination within these countries.
  • Previous experience with epidemics, such as the Ebola virus epidemic, fostered public health preparedness and ingrained preventive behaviors, aiding in lower disease spread.

Conclusions:

  • Limited travel and established public health reflexes from prior epidemics were key factors in the low expansion of Coronavirus disease 2019 (COVID-19) in the studied African nations.
  • Preparedness and response strategies, informed by past epidemic experiences, played a crucial role in managing the pandemic.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
32.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
821
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
311
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
581
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
472
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
262